These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2242 related items for PubMed ID: 18981242

  • 1. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA, Estein SM, García Samartino C, Zwerdling A, Coria LM, Barrionuevo P, Fossati CA, Giambartolomei GH, Cassataro J.
    Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
    [Abstract] [Full Text] [Related]

  • 2. The protein moiety of Brucella abortus outer membrane protein 16 is a new bacterial pathogen-associated molecular pattern that activates dendritic cells in vivo, induces a Th1 immune response, and is a promising self-adjuvanting vaccine against systemic and oral acquired brucellosis.
    Pasquevich KA, García Samartino C, Coria LM, Estein SM, Zwerdling A, Ibañez AE, Barrionuevo P, Oliveira FS, Carvalho NB, Borkowski J, Oliveira SC, Warzecha H, Giambartolomei GH, Cassataro J.
    J Immunol; 2010 May 01; 184(9):5200-12. PubMed ID: 20351187
    [Abstract] [Full Text] [Related]

  • 3. Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection.
    Cassataro J, Estein SM, Pasquevich KA, Velikovsky CA, de la Barrera S, Bowden R, Fossati CA, Giambartolomei GH.
    Infect Immun; 2005 Dec 01; 73(12):8079-88. PubMed ID: 16299302
    [Abstract] [Full Text] [Related]

  • 4. Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice.
    Delpino MV, Estein SM, Fossati CA, Baldi PC, Cassataro J.
    Vaccine; 2007 Sep 17; 25(37-38):6721-9. PubMed ID: 17686554
    [Abstract] [Full Text] [Related]

  • 5. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
    Al-Mariri A, Tibor A, Mertens P, De Bolle X, Michel P, Godefroid J, Walravens K, Letesson JJ.
    Infect Immun; 2001 Aug 17; 69(8):4816-22. PubMed ID: 11447155
    [Abstract] [Full Text] [Related]

  • 6. Survey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis: influence of nanoparticulation versus traditional immunization.
    Abkar M, Lotfi AS, Amani J, Eskandari K, Ramandi MF, Salimian J, Brujeni GN, Alamian S, Kamali M, Koushki H.
    Vet Res Commun; 2015 Dec 17; 39(4):217-28. PubMed ID: 26395469
    [Abstract] [Full Text] [Related]

  • 7. Novel influenza virus vectors expressing Brucella L7/L12 or Omp16 proteins in cattle induced a strong T-cell immune response, as well as high protectiveness against B. abortus infection.
    Tabynov K, Kydyrbayev Z, Ryskeldinova S, Yespembetov B, Zinina N, Assanzhanova N, Kozhamkulov Y, Inkarbekov D, Gotskina T, Sansyzbay A.
    Vaccine; 2014 Apr 11; 32(18):2034-41. PubMed ID: 24598723
    [Abstract] [Full Text] [Related]

  • 8. An IL-15 adjuvant enhances the efficacy of a combined DNA vaccine against Brucella by increasing the CD8+ cytotoxic T cell response.
    Hu XD, Chen ST, Li JY, Yu DH, Yi-Zhang, Cai H.
    Vaccine; 2010 Mar 11; 28(12):2408-15. PubMed ID: 20064480
    [Abstract] [Full Text] [Related]

  • 9. Liposomised recombinant ribosomal L7/L12 protein protects BALB/c mice against Brucella abortus 544 infection.
    Mallick AI, Singha H, Chaudhuri P, Nadeem A, Khan SA, Dar KA, Owais M.
    Vaccine; 2007 May 04; 25(18):3692-704. PubMed ID: 17296251
    [Abstract] [Full Text] [Related]

  • 10. Cell mediated immune response after challenge in Omp25 liposome immunized mice contributes to protection against virulent Brucella abortus 544.
    Goel D, Rajendran V, Ghosh PC, Bhatnagar R.
    Vaccine; 2013 Feb 06; 31(8):1231-7. PubMed ID: 23273966
    [Abstract] [Full Text] [Related]

  • 11. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.
    Grilló MJ, Manterola L, de Miguel MJ, Muñoz PM, Blasco JM, Moriyón I, López-Goñi I.
    Vaccine; 2006 Apr 05; 24(15):2910-6. PubMed ID: 16439039
    [Abstract] [Full Text] [Related]

  • 12. An oral vaccine based on U-Omp19 induces protection against B. abortus mucosal challenge by inducing an adaptive IL-17 immune response in mice.
    Pasquevich KA, Ibañez AE, Coria LM, García Samartino C, Estein SM, Zwerdling A, Barrionuevo P, Oliveira FS, Seither C, Warzecha H, Oliveira SC, Giambartolomei GH, Cassataro J.
    PLoS One; 2011 Jan 14; 6(1):e16203. PubMed ID: 21264260
    [Abstract] [Full Text] [Related]

  • 13. A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination.
    Cassataro J, Pasquevich KA, Estein SM, Laplagne DA, Velikovsky CA, de la Barrera S, Bowden R, Fossati CA, Giambartolomei GH, Goldbaum FA.
    Vaccine; 2007 May 30; 25(22):4437-46. PubMed ID: 17442465
    [Abstract] [Full Text] [Related]

  • 14. Induction of immune response in BALB/c mice with a DNA vaccine encoding bacterioferritin or P39 of Brucella spp.
    Al-Mariri A, Tibor A, Mertens P, De Bolle X, Michel P, Godfroid J, Walravens K, Letesson JJ.
    Infect Immun; 2001 Oct 30; 69(10):6264-70. PubMed ID: 11553569
    [Abstract] [Full Text] [Related]

  • 15. Intradermal immunization with outer membrane protein 25 protects Balb/c mice from virulent B. abortus 544.
    Goel D, Bhatnagar R.
    Mol Immunol; 2012 Jun 30; 51(2):159-68. PubMed ID: 22464098
    [Abstract] [Full Text] [Related]

  • 16. Recombinant outer membrane protein 25c from Brucella abortus induces Th1 and Th2 mediated protection against Brucella abortus infection in mouse model.
    Paul S, Peddayelachagiri BV, Nagaraj S, Kingston JJ, Batra HV.
    Mol Immunol; 2018 Jul 30; 99():9-18. PubMed ID: 29649688
    [Abstract] [Full Text] [Related]

  • 17. Non-infectious outer membrane vesicles derived from Brucella abortus S19Δper as an alternative acellular vaccine protects mice against virulent challenge.
    Solanki KS, Varshney R, Qureshi S, Thomas P, Singh R, Agrawal A, Chaudhuri P.
    Int Immunopharmacol; 2021 Jan 30; 90():107148. PubMed ID: 33189614
    [Abstract] [Full Text] [Related]

  • 18. Intraperitoneal administration of a novel chimeric immunogen (rOP) elicits IFN-γ and IL-12p70 protective immune response in BALB/c mice against virulent Brucella.
    Tadepalli G, Konduru B, Murali HS, Batra HV.
    Immunol Lett; 2017 Dec 30; 192():79-87. PubMed ID: 29106986
    [Abstract] [Full Text] [Related]

  • 19. Immunization of BALB/c mice with a combination of four recombinant Brucella abortus proteins, AspC, Dps, InpB and Ndk, confers a marked protection against a virulent strain of Brucella abortus.
    Hop HT, Arayan LT, Huy TXN, Reyes AWB, Min W, Lee HJ, Park SJ, Chang HH, Kim S.
    Vaccine; 2018 May 17; 36(21):3027-3033. PubMed ID: 29678458
    [Abstract] [Full Text] [Related]

  • 20. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
    Vemulapalli R, Contreras A, Sanakkayala N, Sriranganathan N, Boyle SM, Schurig GG.
    Vet Microbiol; 2004 Sep 08; 102(3-4):237-45. PubMed ID: 15327798
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 113.